Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' TERVAERT JWC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tervaert, JWC; Stegeman, CA; Kallenberg, CGM
      Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    2. Brons, RH; Kallenberg, CGM; Tervaert, JWC
      Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    3. van Leeuwen, EBM; Wisman, GBA; Tervaert, JWC; Palmans, LL; van Wijk, RT; Veenstra, R; Molema, G; van der Zee, AGJ; van der Meer, J; Ruiters, MHJ
      An SV40 large T-antigen immortalized human umbilical vein endothelial cellline for anti-endothelial cell antibody detection

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    4. van der Geld, YM; Simpelaar, A; van der Zee, R; Tervaert, JWC; Stegeman, CA; Limburg, PC; Kallenberg, CGM
      Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptides

      KIDNEY INTERNATIONAL
    5. Heeringa, P; Bijl, M; de Jager-Krikken, A; Zandvoort, A; Dijkstra, G; Moshage, H; Tervaert, JWC; Tiebosch, ATMG; Kallenberg, CGM; van Goor, H
      Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis

      JOURNAL OF PATHOLOGY
    6. Boomsma, MM; Stegeman, CA; Oost-Kort, WW; Kallenberg, CGM; Moguilevsky, N; Limburg, PC; Tervaert, JWC
      Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis

      JOURNAL OF IMMUNOLOGICAL METHODS
    7. Brons, RH; de Jong, MCJM; de Boer, NK; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
      Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis

      ANNALS OF THE RHEUMATIC DISEASES
    8. Kallenberg, CGM; Tervaert, JWC
      New treatments of ANCA-associated vasculitis

      SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
    9. Hewins, P; Tervaert, JWC; Savage, COS; Kallenberg, CGM
      Is Wegener's granulomatosis an autoimmune disease?

      CURRENT OPINION IN RHEUMATOLOGY
    10. Kobold, ACM; Tulleken, JE; Zijlstra, JG; Sluiter, W; Hermans, J; Kallenberg, CGM; Tervaert, JWC
      Leukocyte activation in sepsis; correlations with disease state and mortality

      INTENSIVE CARE MEDICINE
    11. Kas-Deelen, AM; Harmsen, MC; de Maar, EF; Oost-Kort, WW; Tervaert, JWC; van der Meer, J; van Son, WJ; The, TH
      Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood

      KIDNEY INTERNATIONAL
    12. Franssen, CFM; Stegeman, CA; Kallenberg, CGM; Gans, ROB; de Jong, PE; Hoorntje, SJ; Tervaert, JWC
      Antiproteinase 3-and antimyeloperoxidase-associated vasculitis

      KIDNEY INTERNATIONAL
    13. Tervaert, JWC
      Proteinase 3: A cofactor for the binding of antineutrophil cytoplasm antibodies (ANCA) to endothelial cells?

      KIDNEY INTERNATIONAL
    14. Brons, RH; Bakker, HI; Van Wijk, RT; Van Dijk, NW; Kobold, ACM; Limburg, PC; Manson, WL; Kallenberg, CGM; Tervaert, JWC
      Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    15. Molema, G; Tervaert, JWC; Kroesen, BJ; Helfrich, W; Meijer, DKF; de Leij, LFMH
      CD3 directed bispecific antibodies induce increased lymphocyte-endothelialcell interactions in vitro

      BRITISH JOURNAL OF CANCER
    16. Boomsma, MM; Stegeman, CA; van der Leij, MJ; Oost, W; Hermans, J; Kallenberg, CGM; Limburg, PC; Tervaert, JWC
      Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels - A prospective study

      ARTHRITIS AND RHEUMATISM
    17. Foucher, P; Heeringa, P; Petersen, AH; Huitema, MG; Brouwer, E; Tervaert, JWC; Prop, J; Camus, P; Weening, FJ; Kallenberg, CGM
      Antimyeloperoxidase-associated lung disease - An experimental model

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    18. Kallenberg, GGM; Tervaert, JWC
      What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    19. Franssen, CFM; Huitema, MG; Kobold, ACM; Oost-Kort, WW; Limburg, PC; Tiebosch, A; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
      In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    20. Kobold, ACM; van der Geld, YM; Limburg, PC; Tervaert, JWC; Kallenberg, GGM
      Pathophysiology of ANCA-associated glomerulonephritis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    21. Kobold, ACM; van Wijk, RT; Franssen, CFM; Molema, G; Kallenberg, CGM; Tervaert, JWC
      In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    22. Brijker, F; Magee, CC; Tervaert, JWC; O'Neill, S; Walshe, JJ
      Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies

      CLINICAL NEPHROLOGY
    23. Haveman, JW; Kobold, ACM; Tervaert, JWC; van den Berg, AP; Tulleken, JE; Kallenberg, CGM; The, TH
      The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment

      NETHERLANDS JOURNAL OF MEDICINE
    24. Popa, ER; Stegeman, CA; Bos, NA; Kallenberg, CGM; Tervaert, JWC
      Differential B- and T-cell activation in Wegener's granulomatosis

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    25. Dijstelbloem, HM; Scheepers, RHM; Oost, WW; Stegeman, CA; van der Pol, WL; Sluiter, WJ; Kallenberg, CGM; van de Winkel, JGJ; Tervaert, JWC
      Fc gamma receptor polymorphisms in Wegener's granulomatosis - Risk factorsfor disease relapse

      ARTHRITIS AND RHEUMATISM
    26. Choi, HK; Merkel, PA; Tervaert, JWC; Black, RM; McCluskey, RT; Niles, JL
      Alternating antineutrophil cytoplasmic antibody specificity - Drug-inducedvasculitis in a patient with Wegener's granulomatosis

      ARTHRITIS AND RHEUMATISM
    27. Boomsma, MM; Stegeman, CA; Tervaert, JWC
      Comparison of Dutch and US patients' perceptions of the effects of Wegener's granulomatosis on health, function, income, and interpersonal relationships: comment on the article by Hoffman et al

      ARTHRITIS AND RHEUMATISM
    28. Kobold, ACM; Kallenberg, GGM; Tervaert, JWC
      Monocyte activation in patients with Wegener's granulomatosis

      ANNALS OF THE RHEUMATIC DISEASES
    29. Kallenberg, CGM; Heeringa, P; Tervaert, JWC
      Are antineutrophil cytoplasmic antibodies pathogenic in wegener's granulomatosis? Lessons from in vitro and in vivo experimental findings

      DECADE OF AUTOIMMUNITY
    30. FRANSSEN CFM; STEGEMAN CA; OOSTKORT WW; KALLENBERG CGM; LIMBURG PC; TIEBOSCH A; DEJONG PE; TERVAERT JWC
      DETERMINANTS OF RENAL OUTCOME IN ANTI-MYELOPEROXIDASE-ASSOCIATED NECROTIZING CRESCENTIC GLOMERULONEPHRITIS

      Journal of the American Society of Nephrology
    31. TERVAERT JWC; STEGEMAN CA; MANSON WL; KALLENBERG CGM; JOHNSON WM
      STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)

      The FASEB journal
    32. KOBOLD ACM; KALLENBERG CGM; TERVAERT JWC
      LEUKOCYTE MEMBRANE EXPRESSION OF PROTEINASE-3 CORRELATES WITH DISEASE-ACTIVITY IN PATIENTS WITH WEGENERS GRANULOMATOSIS

      British journal of rheumatology (Print)
    33. KOBOLD ACM; TULLEKEN JE; ZIJLSTRA JG; TERVAERT JWC
      INTERLEUKIN-10 IN FEBRILE PATIENTS AND PATIENTS WITH SEPSIS

      Lancet
    34. HEERINGA P; BROUWER E; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
      ANIMAL-MODELS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS

      Kidney international
    35. ROOZENDAAL C; DEWIT AWMV; HAAGSMA EB; HORST G; SCHWARZE C; PETER HH; KLEIBEUKER JH; TERVAERT JWC; LIMBURG PC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - TARGET ANTIGENS AND CLINICAL ASSOCIATIONS

      Gastroenterology
    36. KOBOLD ACM; ZIJLSTRA JG; KOENE HR; DEHAAS M; KALLENBERG CGM; TERVAERT JWC
      LEVELS OF SOLUBLE FC-GAMMA-RIII CORRELATE WITH DISEASE SEVERITY IN SEPSIS

      Clinical and experimental immunology
    37. Kobold, ACM; Mesander, G; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
      Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    38. ROOZENDAAL C; VANMILLEGENDEWIT AWM; HAAGSMA EB; HORST G; SCHWARZE C; PETER HH; KLEIBEUKER JH; TERVAERT JWC; LIMBURG PC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - DEFINED SPECIFICITIES MAY BE ASSOCIATED WITH DISTINCT CLINICAL-FEATURES

      The American journal of medicine
    39. TERVAERT JWC; STEGEMAN CA; MANSON WL; KALLENBERG CGM; JOHNSON WM
      STAPHYLOCOCCUS-AUREUS (SA) SUPERANTIGENS - A RISK FACTOR FOR DISEASE REACTIVATION IN WEGENERS GRANULOMATOSIS (WG)

      Journal of the American Society of Nephrology
    40. FRANSSEN CFM; STEGEMAN CA; DEJONG PE; KALLENBERG CGM; TERVAERT JWC
      KIDNEY SURVIVAL IN PATIENTS WITH ANTIMYELOPEROXIDASE (MPO) ASSOCIATEDGLOMERULONEPHRITIS (GN) IS RELATED TO THE SEVERITY OF PROTEINURIA

      Journal of the American Society of Nephrology
    41. POPA ER; BOS NA; STEGEMAN CA; KALLENBERG CGM; TERVAERT JWC
      SKEWED TCR V-BETA USAGE IN WEGENERS GRANULOMATOSIS SUGGESTS STIMULATION BY SUPERANTIGENS

      Journal of the American Society of Nephrology
    42. POPA ER; STEGEMAN CA; BOS NA; KALLENBERG CGM; TERVAERT JWC
      T-LYMPHOCYTE BUT NOT BETA-LYMPHOCYTE ACTIVATION IN WEGENERS GRANULOMATOSIS PERSISTS DURING REMISSION

      Journal of the American Society of Nephrology
    43. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      COTRIMOXAZOLE AND WEGENERS GRANULOMATOSIS - MORE THAN A COINCIDENCE

      Nephrology, dialysis, transplantation
    44. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      SULFONAMIDES IN VASCULITIDES - WHICH MECHANISM - REPLY

      Nephrology, dialysis, transplantation
    45. BELIZNA C; TERVAERT JWC
      SPECIFICITY, PATHOGENICITY, AND CLINICAL-VALUE OF ANTIENDOTHELIAL CELL ANTIBODIES

      Seminars in arthritis and rheumatism
    46. JAYNE DRW; RASMUSSEN N; ABRAMOWICZ D; TESAR V; RASMUSSEN N; PETERSEN J; JUHL BR; WIIK A; GRONHAGENRISKA C; GUILLEVIN L; LHOTE F; LANDAIS P; LESAVRE P; VANHILLE P; ANDRASSY K; DEGROOT K; GROSS WL; VANDERWOUDE F; BOKI KA; TERVAERT JWC; KALLENBERG CGM; VANES LA; HERMANS J; SIEGERT C; HAGEN EC; FEIGHERY CF; GREGORINI G; FERRARIO F; SINICO RA; DADONIENE J; VASCONCELOS C; MIRAPEIX E; HEIGL Z; PETTERSSON EE; WESTMAN KWA; BACON PA; SAVAGE COS; JAYNE DRW; LOCKWOOD CM; LUQMANI RA; GASKIN G; PUSEY CD; SPECKS U
      TREATMENT OF ANTINEUTROPHIL CYTOPLASM AUTOANTIBODY-ASSOCIATED SYSTEMIC VASCULITIS - INITIATIVES OF THE EUROPEAN-COMMUNITY SYSTEMIC VASCULITIS CLINICAL-TRIALS STUDY-GROUP

      Mayo Clinic proceedings
    47. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
      SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT

      The American journal of pathology
    48. TERVAERT JWC; STEGEMAN CA; KALLENBERG CGM
      SERIAL ANCA TESTING IS USEFUL IN MONITORING DISEASE-ACTIVITY OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIDES

      Sarcoidosis vasculitis and diffuse lung diseases
    49. KALLENBERG CGM; STEGEMAN CA; TERVAERT JWC
      STAPHYLOCOCCUS-AUREUS, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND WEGENERS GRANULOMATOSIS

      Sarcoidosis vasculitis and diffuse lung diseases
    50. TERVAERT JWC
      THE VALUE OF SERIAL ANCA TESTING DURING FOLLOW-UP-STUDIES IN PATIENTSWITH ANCA-ASSOCIATED VASCULITIDES - A REVIEW

      JN. Journal of nephrology
    51. BRIJKER F; TERVAERT JWC; MURPHY R; MAGEE C; MULLOY E; ONEILL S; BROWNE O; CAMPBELL E; WALSHE J
      INITIAL DISEASE-ACTIVITY PREDICTS LONG-TERM DAMAGE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

      Journal of the American Society of Nephrology
    52. FRANSSEN CFM; STEGEMAN CA; OOSTKORT WW; KALLENBERG CGM; TERVAERT JWC
      PROGNOSTIC FACTORS IN ANTIMYELOPEROXIDASE (MPO) ASSOCIATED GLOMERULONEPHRITIS (GN)

      Journal of the American Society of Nephrology
    53. TERVAERT JWC; BAKKER HI; GJALTEMAVANBUITEN L; HEERINGA P; MANSON WL; KALLENBERG CGM
      STAPHYLOCOCCAL ACID-PHOSPHATASE BINDS TO CULTURED ENDOTHELIAL-CELLS AND TO THE GLOMERULAR CAPILLARY WALL IN-VIVO

      Journal of the American Society of Nephrology
    54. KOBOLD ACM; MESANDER G; KALLENBERG CGM; TERVAERT JWC
      INCREASED EXPRESSION OF LEUKOCYTE ADHESION MOLECULES ON CIRCULATING LEUKOCYTES IN ANTINEUTROPHIL CYTOPLASMIC ASSOCIATED (ANCA) VASCULITIS

      The FASEB journal
    55. SPRONK PE; BOOTSMA H; HORST G; HUITEMA MG; LIMBURG PC; TERVAERT JWC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      British journal of rheumatology
    56. FRANSSEN CFM; TERVAERT JWC; STEGEMAN CA; KALLENBERG CGM
      C-ANCA AS A MARKER OF WEGENERS DISEASE

      Lancet
    57. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      COTRIMOXAZOLE IN WEGENERS GRANULOMATOSIS - REPLY

      The New England journal of medicine
    58. STEGEMAN CA; TERVAERT JWC; DEJONG PE; KALLENBERG CGM
      TRIMETHOPRIM-SULFAMETHOXAZOLE (COTRIMOXAZOLE) FOR THE PREVENTION OF RELAPSES OF WEGENERS GRANULOMATOSIS

      The New England journal of medicine
    59. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; KALLENBERG CGM
      SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASE IMMUNIZED BROWN-NORWAY RATS

      Arthritis and rheumatism
    60. KOBOLD ACM; TERVAERT JWC; KLOK PA; KALLENBERG CGM
      INTERVENTION IN EXPERIMENTAL ANTI-MPO ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS BY MONOCLONAL-ANTIBODIES AGAINST ADHESION MOLECULES

      Journal of the American Society of Nephrology
    61. HEERINGA P; FOUCHER P; KLOK RA; HUITEMA MG; TERVAERT JWC; KALLENBERG CGM
      SYSTEMIC INJECTION OF MYELOPEROXIDASE IN MYELOPEROXIDASEIMMUNIZED BROWN-NORWAY RATS

      Journal of the American Society of Nephrology
    62. TERVAERT JWC; STEGEMAN CA; BAKKER H; ARENDS J; MANSON WL; KALLENBERG CGM
      STAPHYLOCOCCUS-AUREUS (SA) IN WEGENERS GRANULOMATOSIS (WG) - A ROLE FOR TOXIC SHOCK SYNDROME TOXIN-1 (TSST-1) PRODUCTION

      Journal of the American Society of Nephrology
    63. STEGEMAN CA; TERVAERT JWC; DEJONG PE; KALLENBERG CGM
      PREVENTION OF RELAPSES OF WEGENERS GRANULOMATOSIS BY TREATMENT WITH COTRIMOXAZOLE - A PLACEBO-CONTROLLED TRIAL

      Journal of the American Society of Nephrology
    64. KOBOLD ACM; TERVAERT JWC; KLOK PA; KALLENBERG CGM
      INTERVENTION IN EXPERIMENTAL ANTI-MPO ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS BY MONOCLONAL-ANTIBODIES AGAINST ADHESION MOLECULES

      Kidney international
    65. STEGEMAN CA; TERVAERT JWC; DEJONG PE; KALLENBERG CGM
      PREVENTION OF RELAPSES OF WEGENERS GRANULOMATOSIS BY TREATMENT WITH TRIMETHOPRIM-SULFAMETHOXAZOLE - A MULTICENTER PLACEBO-CONTROLLED TRIAL

      Kidney international
    66. HAGEN EC; STEGEMAN CA; DAMARO J; SCHREUDER GMT; LEMS SPM; TERVAERT JWC; DEJONG GM; HENE RJ; KALLENBERG CGM; DAHA MR; VANDERWOUDE FJ
      DECREASED FREQUENCY OF HLA-DR13DR6 IN WEGENERS GRANULOMATOSIS

      Kidney international
    67. KALLENBERG CGM; BROUWER E; MULDER AHL; STEGEMAN CA; WEENING JJ; TERVAERT JWC
      ANCA - PATHOPHYSIOLOGY REVISITED

      Clinical and experimental immunology
    68. TERVAERT JWC; STEGEMAN CA
      LONG-TERM FOLLOW-UP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED GLOMERULONEPHRITIS (GN)

      Journal of the American Society of Nephrology
    69. TERVAERT JWC; MULDER AHL; KALLENBERG CGM; STEGEMAN CA
      MEASUREMENT OF IGG3 LEVELS OF ANTI-PROTEINASE-3 ANTIBODIES (APR3) IS USEFUL IN MONITORING DISEASE-ACTIVITY IN WEGENERS GRANULOMATOSIS (WG)

      Journal of the American Society of Nephrology
    70. STEGEMAN CA; TERVAERT JWC; VANSON WJ; TEGZESS AM
      NECROTIZING GLOMERULONEPHRITIS ASSOCIATED WITH ANTIMYELOPEROXIDASE ANTIBODIES IN A RENAL-TRANSPLANT RECIPIENT WITH RENAL-FAILURE OF UNKNOWNORIGIN

      Nephrology, dialysis, transplantation
    71. TERVAERT JWC; STEGEMAN C; BROUWER L; KALLENBERG C
      SERUM LEVELS OF SOLUBLE ADHESION MOLECULES (SVCAM-1, SICAM-1 AND SE-SELECTIN) IN PATIENTS WITH WEGENER GRANULOMATOSIS (WG) - RELATION WITH EXPRESSION OF ADHESION MOLECULES IN KIDNEY BIOPSIES AND RELEVANCE FOR MONITORING DISEASE-ACTIVITY

      The FASEB journal
    72. TERVAERT JWC; STEGEMAN CA; BROUWER E; MULDER AHL; LIMBURG PC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES - A NEW CLASS OF AUTOANTIBODIESIN GLOMERULONEPHRITIS, VASCULITIS AND OTHER INFLAMMATORY DISORDERS

      Netherlands journal of medicine
    73. BROEKROELOFS J; MULDER AHL; NELIS GF; WESTERVELD BD; TERVAERT JWC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN SERA FROM PATIENTS WITH INFLAMMATORY BOWEL-DISEASE (IBD) - RELATION TO DISEASE PATTERN AND DISEASE-ACTIVITY

      Digestive diseases and sciences
    74. TERVAERT JWC; CYBULSKY MI; GIMBRONE MA
      DIFFERENTIAL VASCULAR ENDOTHELIAL EXPRESSION OF ADHESION MOLECULES INA RABBIT MODEL OF GRANULOMATOUS VASCULITIS

      Kidney international
    75. KALLENBERG CGM; BROUWER E; WEENING JJ; TERVAERT JWC
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES - CURRENT DIAGNOSTIC AND PATHOPHYSIOLOGICAL POTENTIAL

      Kidney international
    76. BROUWER E; HUITEMA MG; MULDER AHL; HEERINGA P; VANGOOR H; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
      NEUTROPHIL ACTIVATION IN-VITRO AND IN-VIVO IN WEGENERS GRANULOMATOSIS

      Kidney international
    77. STEGEMAN CA; TERVAERT JWC; HUITEMA MG; DEJONG PE; KALLENBERG CGM
      SERUM LEVELS OF SOLUBLE ADHESION MOLECULES INTERCELLULAR-ADHESION MOLECULE-1, VASCULAR CELL-ADHESION MOLECULE-1, AND E-SELECTIN IN PATIENTSWITH WEGENERS GRANULOMATOSIS - RELATIONSHIP TO DISEASE-ACTIVITY AND RELEVANCE DURING FOLLOW-UP

      Arthritis and rheumatism
    78. TERVAERT JWC; STEGEMAN CA; HUITEMA MG; KALLENBERG CGM
      RELATIONSHIP BETWEEN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-LEVELS AND DISEASE-ACTIVITY IN WEGENERS GRANULOMATOSIS - COMMENT

      Arthritis and rheumatism
    79. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      NASAL CARRIAGE OF STAPHYLOCOCCAL INFECTION IN WEGENER GRANULOMATOSIS - RESPONSE

      Annals of internal medicine
    80. STEGEMAN CA; TERVAERT JWC; SLUITER WJ; MANSON WL; DEJONG PE; KALLENBERG CGM
      ASSOCIATION OF CHRONIC NASAL CARRIAGE OF STAPHYLOCOCCUS-AUREUS AND HIGHER RELAPSE RATES IN WEGENER GRANULOMATOSIS

      Annals of internal medicine
    81. STEGEMAN CA; TERVAERT JWC; KALLENBERG CGM
      ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES - TOOLS FOR DIAGNOSIS AND FOLLOW-UP IN SYSTEMIC VASCULITIS

      Annales de medecine interne
    82. TERVAERT JWC; KALLENBERG C
      NEUROLOGIC MANIFESTATIONS OF SYSTEMIC VASCULITIDES

      Rheumatic diseases clinics of North America
    83. TERVAERT JWC; KALLENBERG CGM
      ANTIMYELOPEROXIDASE ANTIBODIES IN CHURG-STRAUSS-SYNDROME

      Journal of neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 05:26:47